aTyr Pharma, Inc. (LIFE) financial statements (2020 and earlier)

Company profile

Business Address 5791 VAN ALLEN WAY
CARLSBAD, CA 92008
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments261
Cash and cash equivalents256
Short-term investments6
Receivables697
Inventory, net of allowances, customer advances and progress billings403
Inventory403
Derivative instruments and hedges, assets2
Prepaid expense and other current assets143
Other undisclosed current assets119
Total current assets:1,625
Noncurrent Assets
Property, plant and equipment845
Long-term investments and receivables27
Long-term investments27
Intangible assets, net (including goodwill)6,029
Goodwill4,503
Intangible assets, net (excluding goodwill)1,526
Prepaid expense and other noncurrent assets89
Other undisclosed noncurrent assets23
Total noncurrent assets:7,013
TOTAL ASSETS:8,638
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities513
Accounts payable187
Accrued liabilities298
Taxes payable29
Debt353
Deferred compensation liability194
Deferred revenue and credits115
Other undisclosed current liabilities17
Total current liabilities:1,192
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,061
Other undisclosed long-term debt and lease obligation2,061
Liabilities, other than long-term debt603
Pension and other postretirement defined benefit plans, liabilities210
Accrued income taxes106
Deferred tax liabilities, net287
Other undisclosed noncurrent liabilities128
Total noncurrent liabilities:2,792
Total liabilities:3,985
Stockholders' equity
Stockholders' equity attributable to parent4,653
Common stock2
Treasury stock, value(2,482)
Additional paid in capital5,732
Accumulated other comprehensive income59
Retained earnings1,342
Stockholders' equity attributable to noncontrolling interest1
Total stockholders' equity:4,653
TOTAL LIABILITIES AND EQUITY:8,638

Income statement (P&L) ($ in millions)

12/31/2012
Revenues3,799
Cost of revenue(1,372)
Other undisclosed gross profit(292)
Gross profit:2,134
Operating expenses(1,469)
Operating income:665
Nonoperating expense(133)
Interest and debt expense(128)
Other undisclosed income from continuing operations before equity method investments, income taxes128
Income from continuing operations before income taxes:532
Income tax expense(101)
Net income:430
Net income attributable to noncontrolling interest0
Net income available to common stockholders, diluted:431

Comprehensive Income ($ in millions)

12/31/2012
Net income:430
Other comprehensive loss(6)
Comprehensive income:425
Comprehensive loss, net of tax, attributable to noncontrolling interest(0)
Other undisclosed comprehensive income, net of tax, attributable to parent1
Comprehensive income, net of tax, attributable to parent:425

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: